SUBSCRIBE
SUBSCRIBE
News   Business

ARYx Therapeutics, Inc. Reports Second Quarter 2009 Results

August 13, 2009 | 
1 min read

FREMONT, Calif.--(BUSINESS WIRE)--ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of operations and provided a general business update for the second quarter ended June 30, 2009.

Earnings
MORE ON THIS TOPIC
Pictured: Regeneron logo on a light brown building
Earnings
Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure
November 1, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Bristol Myers Squibb in NJ/iStock, arlut
Earnings
BMS Delivers Q3 Beat, Raises 2024 Guidance Amid Strong Demand for Legacy and Newer Drugs
November 1, 2024
 · 
2 min read
 · 
Tristan Manalac
LED Display - Airport flight status board
Layoffs
Compass Delays Pivotal Trial Readouts for Psilocybin in Depression, Lays Off 30% of Staff
October 31, 2024
 · 
2 min read
 · 
Heather McKenzie
Feb 2, 2020 South San Francisco / CA / USA - Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company
Earnings
Merck Lowers Full-Year Sales Guidance Despite Strong Overall Q3 Results
October 31, 2024
 · 
2 min read
 · 
Tristan Manalac